Severity
Moderate
FDA Drug recall · Reported May 26, 2021
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.
Bit & Bet LLC recalled Thumbs Up 7 Blue 69K, 10 capsules, Distributed by Ummzy LLC., Made in USA, UPC 6171358946… - a moderate-severity action.
Thumbs Up 7 Blue 69K, 10 capsules, Distributed by Ummzy LLC., Made in USA, UPC 6171358946… was recalled by Bit & Bet LLC in May 26, 2021. Reason: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.. Check the official notice for the remedy. Verify recall #D-0388-2021 with the FDA Drug before acting.
The recall
Bit & Bet LLC issued this moderate-severity FDA Drug recall-Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil..
Sourced from official FDA Drug enforcement records. Verify recall #D-0388-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0388-2021) was formally reported on May 26, 2021, with the manufacturer initiating the action on March 24, 2021. It is classified under Moderate severity (Class II), with a current status of Terminated. Bit & Bet LLC is listed as the recalling firm, operating out of Cliffside Park, NJ. Federal records list the affected scope as 3894 ten-count boxes (38,940 capsules).
The documented reason for this recall is: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil. Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
3894 ten-count boxes (38,940 capsules)
Related Recalls
6
5 from same agency
Thumbs Up 7 Blue 69K, 10 capsules, Distributed by Ummzy LLC., Made in USA, UPC 617135894673. Packaged in blister foil sheets in a box. Each box contains 10 capsules.
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0388-2021 |
| Date reported | May 26, 2021 |
| Date initiated | March 24, 2021 |
| Recalling firm | Bit & Bet LLC |
| Firm location | Cliffside Park, NJ |
| Affected scope | 3894 ten-count boxes (38,940 capsules) |
| Distribution | Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported May 26, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.